Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Scpharmaceuticals stock in Canada

Own Scpharmaceuticals shares in just a few minutes.

Scpharmaceuticals is a biotechnology business based in the US. Scpharmaceuticals stocks (SCPH.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.26 – a decrease of 5.62% over the previous week. Scpharmaceuticals employs 96 staff and has a market cap (total outstanding stock value) of $400.6 million.

How to buy Scpharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SCPH. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners


National Bank Direct Brokerage

  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Promoted for Low Fees

CIBC Investor's Edge

  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers

  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Scpharmaceuticals stock price (NASDAQ:SCPH)

Use our graph to track the performance of SCPH stocks over time.

Scpharmaceuticals shares at a glance

Information last updated 2023-05-19.
Latest market close$10.57
52-week range$3.68 - $12.75
50-day moving average $9.49
200-day moving average $7.07
Wall St. target price$19.20
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.25

Buy Scpharmaceuticals stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
National Bank Direct Brokerage
Finder Rating:
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
CIBC Investor's Edge
Finder Rating:
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$0 if conditions met, or $100
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.

Is it a good time to buy Scpharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Scpharmaceuticals price performance over time

Historical closes compared with the close of $10.57 from 2023-05-26

1 week (2023-05-19) -5.62%
1 month (2023-04-28) 7.20%
3 months (2023-02-28) 40.93%
6 months (2022-11-28) 45.99%
1 year (2022-05-27) 120.21%
2 years (2021-05-28) 86.75%
3 years (2020-05-28) 26.28%
5 years (2018-05-25) 13.98
[/expander_content] [/expander]

Scpharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -22.24%
Return on equity TTM -57.16%
Profit margin 0%
Book value $2.11
Market capitalisation $400.6 million

TTM: trailing 12 months

Scpharmaceuticals share dividends

We're not expecting Scpharmaceuticals to pay a dividend over the next 12 months.

Scpharmaceuticals share price volatility

Over the last 12 months, Scpharmaceuticals's shares have ranged in value from as little as $3.68 up to $12.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Scpharmaceuticals's is 0.1949. This would suggest that Scpharmaceuticals's shares are less volatile than average (for this exchange).

Scpharmaceuticals overview

scPharmaceuticals Inc. , a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site